Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 4/20 | 0.50 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.45 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.43 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.43 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380846 | 0.94 | TYMP (0.51) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL18797894 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL21305068 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL27153067 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL6396836 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL8381924 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL31419333 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL19493438 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL29792804 | 0.93 | TYMP (0.50) | TYMPP2RY12PRMT6ADORA1 | |
| SCHEMBL19493436 | 0.93 | TYMP (0.55) | TYMPP2RY12PRMT6ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113348181-A | DC-SIGN antibody conjugates comprising a STING agonist | 诺华股份有限公司 | 2021-09-03 | — | — | CN | disclosed |
| CN-111936156-A | Combination of STING agonists and IL-15/IL15-Ra for the treatment of cancer | 诺华股份有限公司 | 2020-11-13 | — | — | CN | disclosed |
| CN-110799218-A | Antibody conjugates comprising STING agonists | 诺华股份有限公司 | 2020-02-14 | — | — | CN | disclosed |